泰凌醫藥：2020年報.pdf

1、Annual Report2020年報(Incorporated in the Cayman Islands with limited liability)(於開曼群島註冊成立之有限公司)CONTENTS 目錄2Financial Highlights財務摘要3Chairmans Statement主席報告6Management Discussion and Analysis管理層討論及分析23Directors and Senior Management董事及高級管理層29Corporate Governance Report企業管治報告55Environmental,Social and

2、Governance Report環境、社會及管治報告101Report of the Directors董事會報告117Board of Directors and Board Committees董事會及董事委員會118Corporate Information公司資料120Independent Auditors Report獨立核數師報告133Consolidated Statement of Profit or Loss綜合損益表135Consolidated Statement of Profit or Loss and Other Comprehensive Income綜合損益

3、及其他全面收益表136Consolidated Statement of Financial Position綜合財務狀況表138Consolidated Statement of Changes in Equity綜合權益變動表139Consolidated Statement of Cash Flows綜合現金流量表142Notes to the Consolidated Financial Statements綜合財務報表附註Financial Highlights財務摘要 China NT Pharma Group Company Limited I Annual Report 202

4、02FIVE-YEAR FINANCIAL SUMMARYResultsFor the year ended 31 December截至12月31日止年度20202019201820172016RMB000RMB000RMB000RMB000RMB000人民幣千元人民幣千元人民幣千元人民幣千元人民幣千元(restated)(restated)（重列）（重列）Turnover營業額221,731153,468571,521604,846359,609Gross profit毛利134,90490,257422,002484,235253,833(Loss)/profit from operati

5、ons經營（虧損）溢利(113,752)(250,766)(480,944)269,57864,575(Loss)/profit before taxation除稅前（虧損）溢利(200,289)(355,141)(561,999)226,42835,543(Loss)/profit for the year from discontinued operations年內來自已終止經營業務的（虧損）溢利(168,644)(237,796)(361,903)(48,916)91,060(Loss)/profit for the year年內（虧損）溢利(359,913)(593,202)(963,

6、762)161,629115,760 Assets and LiabilitiesAt 31 December於12月31日20202019201820172016RMB000RMB000RMB000RMB000RMB000人民幣千元人民幣千元人民幣千元人民幣千元人民幣千元 Total non-current assets非流動資產總值718,1101,488,9301,637,0711,670,5761,578,145 Total current assets流動資產總值480,860309,344590,0911,089,143984,594Total current liabilitie